Skip to main content
. 2012 Aug 17;12:124. doi: 10.1186/1471-2431-12-124

Table 2.

Growth outcomes and human milk fortification for all subjects and by human milk intake

 
 
Group by proportion of enteral intake as human milk
pvalue
  All Subjects <25% 25-50% 50-75% >75% All groups >75% vs. <75%
Discharge weight, g, median (IQR)
2782 (2460, 3215)
3005 (2470, 3260)
2765 (2500, 3690)
2980 (2695, 3280)
2685 (2335, 3035)
0.008*
0.0006
Discharge weight z- score, median (IQR)
−0.94 (−1.43, -0.19)
−0.72 (−1.43, -0.19)
−0.69 (−1.36, -0.05)
−0.95 (−1.28, 0.12)
−1.07 (−1.52, -0.29)
0.36*
0.09
SGA at discharge n (%)
58 (34)
7 (41)
8 (27)
9 (25)
34 (39)
0.36*
0.18
Protein fortification, highest level
 
 
 
 
 
 
 
n (%)
 
 
 
 
 
 
 
2.0-2.3 g/dl
34 (20)
6 (35)
8 (27)
6 (17)
14 (16)
0.04
0.18
2.4-2.65 g/dl
84 (49)
6 (35)
14 (46)
16 (44)
48 (55)
 
 
2.5-2.7 g/dl
53 (31)
5 (29)
8 (27)
14 (39)
26 (30)
 
 
Change in weight z-score, birth to discharge, median (IQR) −0.51‡ (−0.89, -0.03) −0.1 (−0.61, 0.16) −0.30 (−0.85, 0) −0.32 (−0.73, 0.15) −0.60 (−0.99, -0.15) 0.17* 0.03

*ANOVA or Chi square across all groups.

Chi square across all fortification levels and all human milk intake groups.

‡ p < 0.0001 – t-test of change in weight z score = 0, infants experienced significant negative change in weight z-score from birth to discharge.

HHS Vulnerability Disclosure